DT

Dyno Therapeutics

Verified

Dyno Therapeutics uses artificial intelligence for gene therapy. Healthcare Biotech Artificial Intelligence

About Dyno Therapeutics

Dyno Therapeutics is tracked on 100Xfounder as a healthcare company, founded in 2018, based in Boston, Massachusetts, USA, currently mapped to the Series A stage. Dyno Therapeutics uses artificial intelligence for gene therapy. Healthcare Biotech Artificial Intelligence

Profile snapshot: Founders linked: Dyno Therapeutics Team. Funding tracked: $100.00M. Hiring focus: Open Roles. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

  • Dyno Therapeutics appears in the 100Xfounder startup directory import feed.

Why it Matters

Dyno Therapeutics is worth tracking because its funding history is already mapped here, including a $100.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Dyno Therapeutics Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $100.00MLast Round: Series A Andreessen Horowitz, $100M Series A in 2021All Rounds: 1
  • Series A | Andreessen Horowitz, $100M Series A in 2021

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: June 1, 2026

Dyno Therapeutics research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    Dyno Therapeutics uses artificial intelligence for gene therapy. Healthcare Biotech Artificial Intelligence

  • Founders covered

    Dyno Therapeutics Team

  • Market position

    Healthcare | Series A | Boston, Massachusetts, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $100.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Dyno Therapeutics.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Dyno Therapeutics

Common questions people ask about this profile.

What is Dyno Therapeutics?

Dyno Therapeutics uses artificial intelligence for gene therapy. Healthcare Biotech Artificial Intelligence

Who founded Dyno Therapeutics?

Dyno Therapeutics is associated with Dyno Therapeutics Team on 100Xfounder.

Where is Dyno Therapeutics located?

Dyno Therapeutics is listed in Boston, Massachusetts, USA.

What stage is Dyno Therapeutics in?

Dyno Therapeutics is currently mapped to Series A. Funding context: Andreessen Horowitz, $100M Series A in 2021

What is the latest funding round of Dyno Therapeutics?

Dyno Therapeutics's latest tracked round is Series A Andreessen Horowitz, $100M Series A in 2021. Total tracked rounds: 1.

Is Dyno Therapeutics hiring now?

Dyno Therapeutics hiring status: Open Roles.

What technologies does Dyno Therapeutics use?

Dyno Therapeutics is associated with Python, GCP, BigQuery, and React.

Is Dyno Therapeutics verified on 100Xfounder?

Yes. Dyno Therapeutics is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with Dyno Therapeutics founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.